CASTRATION-RESISTANT PROSTATE CANCER (CRPC)
Clinical trials for CASTRATION-RESISTANT PROSTATE CANCER (CRPC) explained in plain language.
Never miss a new study
Get alerted when new CASTRATION-RESISTANT PROSTATE CANCER (CRPC) trials appear
Sign up with your email to follow new studies for CASTRATION-RESISTANT PROSTATE CANCER (CRPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heated cell therapy targets prostate cancer tumors
Disease control Not yet recruitingThis early-stage study is testing a new type of CAR-T cell therapy, called ACT#001, for men with advanced prostate cancer that no longer responds to hormone therapy. The therapy involves collecting a patient's own immune cells, genetically modifying them to target a protein on pr…
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER (CRPC)
Phase: EARLY_PHASE1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Mar 18, 2026 14:42 UTC
-
New imaging agent seeks to light up hidden cancer
Diagnosis Not yet recruitingThis early-stage study is testing a new imaging agent called 111In-ABD147 to see if it can detect metastatic cancer in patients with solid tumors. The agent is designed to attach to a protein called DLL3, which is often found on certain cancer cells. The main goals are to see if …
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER (CRPC)
Phase: EARLY_PHASE1 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated Mar 30, 2026 14:33 UTC